Home > Insider Trading > Filing (0001209191-21-056526)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645569	Dice Therapeutics Inc.	DICE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1356950	Paul James Scopa	C/O Dice Therapeutics, Inc. 279 E. Grand Avenue, Suite 300, Lobby B South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-15	6,000	$17.00	55,841	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2021-09-14	12,096	$0.00	12,096	$17.00
Common Stock	Stock Option (right to buy)	Acquisiton	2021-09-14	8,261	$0.00	8,261	$17.00
Common Stock	Stock Option (right to buy)	Acquisiton	2021-09-14	8,200	$0.00	8,200	$17.00
Common Stock	Stock Option (right to buy)	Acquisiton	2021-09-14	5,600	$0.00	5,600	$17.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,096	2031-09-14	No	4	A	Direct
8,261	2031-09-14	No	4	A	Direct
8,200	2031-09-14	No	4	A	Direct
5,600	2031-09-14	No	4	A	Direct

Footnotes

The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
The option vests as to 1/36th of the total shares monthly, beginning November 8, 2020, subject to the Reporting Holder's continued service to the Registrant.
The option vests as to 1/36th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continued service to the Registrant.
The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant.